32 reports

They' ll have ##% pain relief. "

  • Type 2 Diabetes
  • Forecast
  • Daiichi Sankyo Company
  • Depomed, Inc.
  • Pfizer Inc.
  • MARKET CHALLENGES

There is a high demand for treatment that is characterized by effective and sustained pain relief, patient tolerability, low cost, and minimal side effects.

  • Type 2 Diabetes
  • Depomed, Inc.
  • Eli Lilly & Co.
  • Endo International plc
  • Pfizer Inc.

EpiCept NP-## is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

  • Therapy
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • ViroMed Co., Ltd.
  • PIPELINE BY GLAXOSMITHKLINE PLC, H1 2018

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases.

  • Diabetes
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • GlaxoSmithKline plc

EpiCept NP-## is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

  • Neurological Disorder
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • ViroMed Co., Ltd.
  • PIPELINE BY DONG-A SOCIO HOLDINGS CO LTD, H1 2018

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Pharmaceutical
  • Type 2 Diabetes
  • United States
  • World
  • Product Initiative
  • DIABETIC FOOT ULCERS - PIPELINE BY GLAXOSMITHKLINE PLC, H1 2018
  • DIABETIC FOOT ULCERS - PIPELINE BY GENENTECH INC, H1 2018

Until now, most of the medications prescribed for diabetic neuropathy have largely been analgesics aimed for pain relief.

  • Chronic Disease
  • Therapy
  • Type 2 Diabetes
  • Wound Care
  • ProMetic Life Sciences Inc.
  • Clinical Trial profile. 141 Trial Title

Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2018" provides an overview of Peripheral Neuropathy (Sensory Neuropathy) clinical trials scenario.This...

  • Chemotherapy
  • Clinical Trial
  • Type 2 Diabetes
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Chemotherapy
  • Clinical Trial
  • Type 2 Diabetes
  • World
  • Product Initiative
  • XK-568B - DRUG PROFILE

EpiCept NP-## is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

  • Neurological Disorder
  • Pharmaceutical
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • DIABETIC NEPHROPATHY - PIPELINE BY PARANTA BIOSCIENCES LTD, H2 2018
  • DIABETIC NEPHROPATHY - PIPELINE BY PHYTOHEALTH CORP, H2 2018

The primary outcomes are pain relief by VAS scores of most pain, least pain and average pain by questionnaire.

  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative
  • ProMetic Life Sciences Inc.

In addition, pain relief was also observed in those patients that were not taking a single existing medicine for their PHN.

  • Therapy
  • Type 2 Diabetes
  • Australia
  • World
  • Product Initiative
  • XK-568B - DRUG PROFILE
  • CIBINETIDE - DRUG PROFILE

The primary outcomes are pain relief by VAS scores of most pain, least pain and average pain by questionnaire.

  • Neurological Disorder
  • Therapy
  • Type 2 Diabetes
  • United States
  • Product Initiative

In addition, pain relief was also observed in those patients that were not taking a single existing medicine for their PHN.

  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • World
  • Product Initiative

The data demonstrated that CINGAL provided improved immediate and short term pain relief after injection as compared to HA alone, and enhanced relief from OA-related pain, stiffness and function through ## weeks as compared to saline.

  • Plastic Surgery
  • Type 2 Diabetes
  • United States
  • Company Financials
  • GlobalData's company

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Type 2 Diabetes
  • Turkey
  • United States
  • World
  • Product Initiative

The company provides products to therapeutics areas which include pain relief, inflammation, CNS, cold & flu, oral care & sore throat, gynecology, disinfection.

  • Type 2 Diabetes
  • United States
  • World
  • Product Initiative
  • DiaMedica Inc.

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Chronic Disease
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative
  • CIBINETIDE - DRUG PROFILE

The primary outcomes are pain relief by VAS scores of most pain, least pain and average pain by questionnaire.

  • Neurological Disorder
  • Type 2 Diabetes
  • United States
  • World
  • Product Initiative
  • DIABETIC FOOT ULCERS - PIPELINE BY GENENTECH INC, H2 2017
  • DIABETIC FOOT ULCERS - PIPELINE BY GLAXOSMITHKLINE PLC, H2 2017

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Chronic Disease
  • Therapy
  • Type 2 Diabetes
  • Wound Care
  • Product Initiative
  • 5. All the trials included are unique trials.

Aflibercept in Patients with Diabetic Macular Edema Evaluation of Inflammation and Pain Post Injection of Ranibizumab Vs.

  • Clinical Trial
  • Endocrine Disease
  • Pharmaceutical
  • Type 2 Diabetes
  • World
  • TYPE 2 DIABETES - PIPELINE BY GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED, H2 2016
  • TYPE 2 DIABETES - PIPELINE BY GLAXOSMITHKLINE PLC, H2 2016

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Biotechnology
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative
  • TYPE 2 DIABETES - PIPELINE BY GILEAD SCIENCES INC, H2 2017
  • TYPE 2 DIABETES - PIPELINE BY CENTER LABORATORIES INC, H2 2017

The primary outcomes are pain relief by VAS scores of most pain, least pain and average pain by questionnaire.

  • Biopharmaceutical
  • Pathology
  • Type 2 Diabetes
  • United States
  • Company

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Ophthalmology
  • Type 2 Diabetes
  • Company
  • Product Initiative
  • Allergan plc
  • DIABETIC NEPHROPATHY - PIPELINE BY PHILOGENE INC, H1 2018
  • DIABETIC NEPHROPATHY - PIPELINE BY PHYTOHEALTH CORP, H1 2018

The primary outcomes are pain relief by VAS scores of most pain, least pain and average pain by questionnaire.

  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • CIBINETIDE - DRUG PROFILE

The primary outcomes are pain relief by VAS scores of most pain, least pain and average pain by questionnaire.

  • Chronic Disease
  • Therapy
  • Type 2 Diabetes
  • United States
  • Product Initiative

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Autoimmune Disease
  • Therapy
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • CIBINETIDE - DRUG PROFILE

The primary outcomes are pain relief by VAS scores of most pain, least pain and average pain by questionnaire.

  • Neurological Disorder
  • Neurology
  • Type 2 Diabetes
  • United States
  • Company Operations

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Diabetes
  • Obesity
  • Therapy
  • Type 2 Diabetes
  • Omeros Corporation

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Pharmaceutical
  • Type 2 Diabetes
  • United States
  • Company
  • Product Initiative